Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis

Go back to Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis
Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) Delayed: 5.83 +0.26 (4.67%)
Previous Close $5.57    52 Week High $5.95 
Open $5.59    52 Week Low $4.20 
Day High $5.95    P/E 97.17 
Day Low $5.50    EPS $0.06 
Volume 51,660